Saturday, May 28, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | News | Covaxin Demonstrates Protection Against New Variants Study

Covaxin demonstrates protection against new variants: Study

By IANS
Published: Published Date - 01:27 PM, Sun - 16 May 21
Representational Image. A modest reduction in neutralisation by a factor of 1.95 was observed against B1617 variant compared to vaccine variant.

New Delhi: Peer-review publication, Clinical Infectious Diseases, has noted that Covaxin demonstrates protection against the new Covid-19 variants.

Bharat Biotech’s Covaxin retained neutralising activity against emerging variants of coronavirus, as per a new study.

A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.

A modest reduction in neutralisation by a factor of 1.95 was observed against B1617 variant compared to vaccine variant.

Despite this reduction, neutralising titre levels with B 1617 remain above levels expected to be protective.

No difference in neutralisation between B 117 first identified in the UK and vaccine strain was observed.

The study was conducted in collaboration with National Institute of Virology and Indian Council of Medical Research.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • B 117
  • B 1617
  • Bharat Biotech’s Covaxin
  • Clinical Infectious Diseases

Related News

  • ‘Omicron less severe than Delta’

  • Editorial: To boost or not to boost?

  • Bahrain approves Bharat Biotech’s Covaxin for emergency use

  • Bharat Biotech’s partner seeks Covaxin approval in US for children below 18 years

  • Bharat Biotech’s Covaxin recognized by Australia

  • Decision on Bharat Biotech’s Covaxin in October: WHO

Latest News

  • Telangana youth makes it to IIM-A, proves poverty no hurdle

    20 mins ago
  • Make 5th phase of Palle Pragathi grand success: Nalgonda ZP Chairman

    23 mins ago
  • ‘Increase pension for retired First Class cricketers’

    24 mins ago
  • Haritha Haram spreads its roots in Telangana

    30 mins ago
  • GHMC swimming pools back with a splash

    32 mins ago
  • Telangana Residential School students excel at national level

    33 mins ago
  • TSEWIDC chief inspects Mana Ooru Mana Badi works

    39 mins ago
  • NRI Velamas write open letter to Revanth Reddy

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam